Essex Investment Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,547
Closed -$508K 422
2021
Q2
$508K Hold
5,547
0.06% 277
2021
Q1
$378K Sell
5,547
-576
-9% -$44.7K 0.05% 309
2020
Q4
$444K Buy
+6,123
New +$355K 0.06% 298
2019
Q3
Sell
-35,779
Closed -$1.29M 471
2019
Q2
$1.29M Buy
35,779
+13,612
+61% +$436K 0.18% 188
2019
Q1
$699K Buy
+22,167
New +$646K 0.1% 235
2017
Q1
Sell
-103,902
Closed -$281K 351
2016
Q4
$281K Buy
+103,902
New +$360K 0.05% 300

Other funds holding CDNA

Essex Investment Management's CDNA Position: Q3 2021 in Review

Essex Investment Management sold out of CareDx (CDNA) in Q3 2021, closing a stake of 5,547 shares — an estimated $508K sold.

Essex Investment Management first reported a position in CDNA in Q4 2016 and held it in 6 quarters. The position peaked at $1.29M in Q2 2019. 260 funds tracked by Wall St. Rank hold CDNA as of Q3 2021.

  • Essex Investment Management reported no remaining CareDx position as of Q3 2021 after selling out during the quarter.
  • Essex Investment Management sold 5,547 CareDx shares in Q3 2021, an estimated $508K.
  • Essex Investment Management first reported a position in CareDx in Q4 2016 and held it in 6 quarters.
  • Essex Investment Management's CareDx position peaked at $1.29M in Q2 2019.
  • 260 funds tracked by Wall St. Rank held CareDx as of Q3 2021.

Based on Essex Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.